787 related articles for article (PubMed ID: 11923230)
1. Assessment of the impact of vision impairment.
Weih LM; Hassell JB; Keeffe J
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):927-35. PubMed ID: 11923230
[TBL] [Abstract][Full Text] [Related]
2. The determinants of participation in activities of daily living in people with impaired vision.
Lamoureux EL; Hassell JB; Keeffe JE
Am J Ophthalmol; 2004 Feb; 137(2):265-70. PubMed ID: 14962415
[TBL] [Abstract][Full Text] [Related]
3. Assessing participation in daily living and the effectiveness of rehabiliation in age related macular degeneration patients using the impact of vision impairment scale.
Lamoureux EL; Pallant JF; Pesudovs K; Tennant A; Rees G; O'Connor PM; Keeffe JE
Ophthalmic Epidemiol; 2008; 15(2):105-13. PubMed ID: 18432494
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis.
Lamoureux EL; Pallant JF; Pesudovs K; Hassell JB; Keeffe JE
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4732-41. PubMed ID: 17065481
[TBL] [Abstract][Full Text] [Related]
5. Validity of a visual impairment questionnaire in measuring cataract surgery outcomes.
Pesudovs K; Caudle LE; Rees G; Lamoureux EL
J Cataract Refract Surg; 2008 Jun; 34(6):925-33. PubMed ID: 18498997
[TBL] [Abstract][Full Text] [Related]
6. The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and rasch analysis.
Lamoureux EL; Pallant JF; Pesudovs K; Rees G; Hassell JB; Keeffe JE
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1001-6. PubMed ID: 17325138
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a vision-specific quality-of-life questionnaire for Timor-Leste.
du Toit R; Palagyi A; Ramke J; Brian G; Lamoureux EL
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4284-9. PubMed ID: 18502996
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Vision Impairment for Children (IVI_C): validation of a vision-specific pediatric quality-of-life questionnaire using Rasch analysis.
Cochrane GM; Marella M; Keeffe JE; Lamoureux EL
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1632-40. PubMed ID: 21178144
[TBL] [Abstract][Full Text] [Related]
9. Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration.
Revicki DA; Rentz AM; Harnam N; Thomas VS; Lanzetta P
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):712-7. PubMed ID: 19797233
[TBL] [Abstract][Full Text] [Related]
10. Predicting the need for low vision rehabilitation services.
O'Connor PM; Lamoureux EL; Keeffe JE
Br J Ophthalmol; 2008 Feb; 92(2):252-5. PubMed ID: 18227205
[TBL] [Abstract][Full Text] [Related]
11. Impact of the severity of distance and near-vision impairment on depression and vision-specific quality of life in older people living in residential care.
Lamoureux EL; Fenwick E; Moore K; Klaic M; Borschmann K; Hill K
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4103-9. PubMed ID: 19357359
[TBL] [Abstract][Full Text] [Related]
12. Vision-specific distress and depressive symptoms in people with vision impairment.
Rees G; Tee HW; Marella M; Fenwick E; Dirani M; Lamoureux EL
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2891-6. PubMed ID: 20164466
[TBL] [Abstract][Full Text] [Related]
13. Relationship between visual impairment and eye diseases and visual function in Andhra Pradesh.
Nutheti R; Keeffe JE; Shamanna BR; Nirmalan PK; Krishnaiah S; Thomas R
Ophthalmology; 2007 Aug; 114(8):1552-7. PubMed ID: 17678693
[TBL] [Abstract][Full Text] [Related]
14. Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: Proyecto VER.
Broman AT; Munoz B; West SK; Rodriguez J; Sanchez R; Snyder R; Klein R
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):606-13. PubMed ID: 11222517
[TBL] [Abstract][Full Text] [Related]
15. Measuring outcomes of vision rehabilitation with the Veterans Affairs Low Vision Visual Functioning Questionnaire.
Stelmack JA; Szlyk JP; Stelmack TR; Demers-Turco P; Williams RT; Moran D; Massof RW
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3253-61. PubMed ID: 16877389
[TBL] [Abstract][Full Text] [Related]
16. Vision and quality of life: the development of a utility measure.
Misajon R; Hawthorne G; Richardson J; Barton J; Peacock S; Iezzi A; Keeffe J
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4007-15. PubMed ID: 16249474
[TBL] [Abstract][Full Text] [Related]
17. Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma.
Parrish RK
Trans Am Ophthalmol Soc; 1996; 94():919-1028. PubMed ID: 8981717
[TBL] [Abstract][Full Text] [Related]
18. Development of a questionnaire to assess vision problems under low luminance in age-related maculopathy.
Owsley C; McGwin G; Scilley K; Kallies K
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):528-35. PubMed ID: 16431946
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
20. The development of the Melbourne low-vision ADL index: a measure of vision disability.
Haymes SA; Johnston AW; Heyes AD
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1215-25. PubMed ID: 11328730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
